CCS HCS SB 407 -- CANCER SCREENINGS Current law requires health insurers to provide coverage to cancer patients for routine patient costs incurred as a result of drugs and devices used in clinical trials, even if those drugs and devices have not been approved by the United States Food and Drug Administration for use in treating the patient's particular condition. This bill clarifies that accident-only policies, specified disease policies, Medicare supplement policies, and other types of limited benefit health insurance policies are exempt from this mandate.